Marton Laurence 4
4 · RenovoRx, Inc. · Filed Nov 4, 2022
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Marton Laurence
Director
Transactions
- Exercise/Conversion
Common Stock
2022-11-03$1.70/sh+25,438$43,245→ 25,438 total - Exercise/Conversion
Stock Option (right to buy)
2022-11-03−25,438→ 0 totalExercise: $1.70Exp: 2023-04-02→ Common Stock (25,438 underlying)
Footnotes (1)
- [F1]Shares subject to the option are fully vested and immediately exercisable.